Potential of Malawi’s medicinal plants in Covid-19 disease management: A review
Open Access
- 30 June 2021
- journal article
- review article
- Published by African Journals Online (AJOL) in Malawi Medical Journal
- Vol. 33 (2), 85-107
- https://doi.org/10.4314/mmj.v33i2.4
Abstract
The Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered an international pandemic that has led to significant public health problems. To date, limited evidence exists to suggest that drugs are effective against the disease. As possible treatments are being investigated, herbal medicines have shown potential for producing novel antiviral agents for the COVID-19 disease. Aim This review explored the potential of Malawi’s traditional medicinal plants for the management of COVID-19. Methods The authors searched on PubMed and Google scholar for medicinal plants that are used in Malawi and published in openly available peer reviewed journals. Plants linked with antiviral treatment, anti-COVID-19 activity or COVID-19 symptoms management were targeted. These included activity against pneumonia, inflammation, cough, difficulty in breathing, pain/aches, fever, diarrhoea, rheumatism, fatigue, asthma, immunocompromised and cardiovascular diseases. Results 11 studies were found with 306 plant species. 127 plant species had at least one COVID-19 related pharmacological activity. Of these plant species, the number of herbal entities used for each indication was: pain/aches (87), fever (2), pneumonia (9), breathing/asthma problems (5), coughing (11), diarrhoea (1), immunosuppression (8), blood issues (10), fatigue (2), heart problems (11), inflammation (8), rheumatism (10) and viral diseases (12). Thirty (30) species were used for more than one disease and Azedarachta indica topped the list (6 of the 13 COVID-19 related diseases). The majority of the species had phytochemicals known to have antiviral activity or mechanisms of actions linked to COVID-19 and consequent diseases’ treatment pathways. Conclusion Medicinal plants are a promising source of compounds that can be used for drug development of COVID-19 related diseases. This review highlights potential targets for the World Health Organization and other research entities to explore in order to assist in controlling the pandemic.Keywords
This publication has 80 references indexed in Scilit:
- Bioactivities of the Genus Combretum (Combretaceae): A ReviewMolecules, 2012
- Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetesClinical and Experimental Immunology, 2012
- Measles vaccination in humanitarian emergencies: a review of recent practiceConflict and Health, 2011
- Dengue fever treatment with Carica papaya leaves extractsAsian Pacific Journal of Tropical Biomedicine, 2011
- The global burden of bacterial and viral zoonotic infectionsClinical Microbiology & Infection, 2011
- Screening for Antiviral Activities of Isolated Compounds from Essential OilsEvidence-Based Complementary and Alternative Medicine, 2011
- Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibitionBioorganic & Medicinal Chemistry, 2010
- Potential of Complementary and Alternative Medicine in Preventive Management of Novel H1N1 Flu (Swine Flu) Pandemic: Thwarting Potential Disasters in the BudEvidence-Based Complementary and Alternative Medicine, 2010
- Coronavirus Genomics and Bioinformatics AnalysisViruses, 2010
- Sclerocarya birrea (a. rich) hochst. [‘marula’] (anacardiaceae): a review of its phytochemistry, pharmacology and toxicology and its ethnomedicinal usesPhytotherapy Research, 2009